Shah Pratik

Shah Pratik is listed in filings as Director at ARS Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including 9 public disclosures. Recent filings connect the profile to ARS Pharmaceuticals, Inc. (SPRY) and Design Therapeutics, Inc. (DSGN). The current snapshot covers public activity from Jun 17, 2024 to Jan 5, 2026. Reported amounts are shown as $309.2K to $3.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.